These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27870056)

  • 1. Cure of cancer for seven cancer sites in the Flemish Region.
    Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L
    Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion cured models applied to 23 cancer sites in Norway.
    Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
    Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
    Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
    Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
    Eriksson H; Lyth J; Andersson TM
    Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cure of cancer: a European perspective.
    Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
    Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
    AIRTUM Working Group
    Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.
    Yeole BB; Kumar AV
    Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Engholm G; Storm HH; Tryggvadóttir L; Gislum M; Hakulinen T; Bray F
    Acta Oncol; 2010 Jun; 49(5):578-607. PubMed ID: 20491524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of cancer survival in developing countries.
    Sankaranarayanan R; Black RJ; Swaminathan R; Parkin DM
    IARC Sci Publ; 1998; (145):135-73. PubMed ID: 10194635
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
    Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
    Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific proportion cured models applied to cancer registry data.
    Edlinger M; Ulmer H; Cvancarova M; Oberaigner W
    Cancer Causes Control; 2014 Mar; 25(3):365-73. PubMed ID: 24442714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.
    Tai P; Yu E; Cserni G; Vlastos G; Royce M; Kunkler I; Vinh-Hung V
    BMC Cancer; 2005 May; 5():48. PubMed ID: 15904508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Trends in Population-Level Cure of Cancer: The Australian Context.
    Kou K; Dasgupta P; Cramb SM; Yu XQ; Baade PD
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):625-635. PubMed ID: 31932416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term clinical course of patients with cutaneous melanoma.
    Gamel JW; George SL; Edwards MJ; Seigler HF
    Cancer; 2002 Sep; 95(6):1286-93. PubMed ID: 12216097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-to-cure and cure proportion in solid cancers in France. A population based study.
    Romain G; Boussari O; Bossard N; Remontet L; Bouvier AM; Mounier M; Iwaz J; Colonna M; Jooste V;
    Cancer Epidemiol; 2019 Jun; 60():93-101. PubMed ID: 30933890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
    Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
    J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.